Evidence map›Paper›PMID 35261547›Full record

ReviewOpen access journal of sports medicine2022

Cross-Communication Between Knee Osteoarthritis and Fibrosis: Molecular Pathways and Key Molecules.

Ioanna K Bolia, Kevin Mertz, Ethan Faye, Justin Sheppard, Sagar Telang, Jacob Bogdanov, Laith K Hasan, Aryan Haratian, Denis Evseenko, Alexander E Weber and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Open access journal of sports medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ioanna K BoliaUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0002-9410-1421
Kevin MertzUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.
Ethan FayeUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0001-9376-6096
Justin SheppardUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.
Sagar TelangUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0001-5242-9093
Jacob BogdanovUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0002-1064-7487
Laith K HasanUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0001-8978-4638
Aryan HaratianUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0002-0125-4518
Denis EvseenkoUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.
Alexander E WeberUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.
Frank A PetriglianoUSC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA.ORCID 0000-0001-8816-6256
Keck Hospital of USC · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
GP130/STAT3 signalling in articular cartilage development and regenerationR01AR071734 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EVSEENKO, DENIS, LYONS, KAREN M. · 2018 to 2022
$3.0M
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilageR01AG058624 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EVSEENKO, DENIS · 2019 to 2023
$1.7M
NCATS NIH HHS UL1 TR001855NIAMS NIH HHS R01 AR071734NIA NIH HHS R01 AG058624
6 · The paper itself

Abstract

Knee fibrosis is characterized by the presence of excessive connective tissue due to dysregulated fibroblast activation following local or systemic tissue damage. Knee fibrosis constitutes a major clinical problem in orthopaedics due to the severe limitation in the knee range of motion that leads to compromised function and patient disability. Knee osteoarthritis is an extremely common orthopedic condition that is associated with patient disability and major costs to the health-care systems worldwide. Although knee fibrosis and osteoarthritis (OA) have traditionally been perceived as two separate pathologic entities, recent research has shown common ground between the pathophysiologic processes that lead to the development of these two conditions. The purpose of this review was to identify the pathophysiologic pathways as well as key molecules that are implicated in the development of both knee OA and knee fibrosis in order to understand the relationship between the two diagnoses and potentially identify novel therapeutic targets.

Indexed as

fibrosiskneemoleculesosteoarthritis

Identifiers

PMID35261547
PMCPMC8898188
OpenAlexW4214750248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.